COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Washington D.C. patients with a documented clinical need may be eligible for compounded tirzepatide.
D.C. residents benefit from proximity to some of the nation's top medical institutions and a dense healthcare network. Compounding Finder helps D.C. patients compare licensed pharmacies.
Yes. The D.C. Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.